Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(22%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
8
89%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed3
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (11.1%)
N/A8 (88.9%)

Trials by Status

unknown333%
terminated111%
completed333%
recruiting222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9